Company / Gross Profit
Baxter International Gross Profit History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$3.4B
FY2025
5-year range
$3.4B / $4.7B
FY2021-FY2025
Trend
-15.2%
vs FY2024
Sector context
#15 of 100
Health Care
What the data says
Baxter International's gross profit of $3.4B is higher than 85% of companies in the Health Care sector (FY2025). Gross Profit has fluctuated over the past 10 years, ranging from $3.4B in FY2025 to $4.8B in FY2018.
Based on SEC 10-K filings.
$3.4B in FY2025 with a 5-year CAGR of -5.9%. Top quartile in the Health Care sector.
Declined from $4.2B to $3.4B over the past 2 years.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- -1.6%
- 5-Year CAGR
- -5.9%
- 10-Year CAGR
- -
Sector benchmark
Top 15% in Health CareTop 15% of 100This company $3.4B Sector average $1.8B
▼
+86.1% above sector average
Key checks
Key Insights
- 5-year CAGR of -5.9%, indicating a declining trend.
- In FY2025, gross profit decreased 15.2% year-over-year.
- Ranks #15 out of 100 companies in the Health Care sector.
- Peak gross profit was recorded in FY2018.
Company context
Key Data Points
- Negative profit margin: -6.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.4B | -15.2% |
| FY2024 | $4.0B | -4.0% |
| FY2023 | $4.2B | +16.9% |
| FY2022 | $3.5B | -24.8% |
| FY2021 | $4.7B | +2.9% |
| FY2020 | $4.6B | +2.5% |
| FY2019 | $4.5B | -6.0% |
| FY2018 | $4.8B | +6.4% |
| FY2017 | $4.5B | -2.3% |
| FY2016 | $4.6B | +10.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026